2021-10-15
CTBE raised fund from SUCCESS program of Japan Science and Technology Agency (JST) . The company will accelerate development of the artificial ligament for ACL reconstruction and business development for the US market.
CTBE raised fund from SUCCESS program of Japan Science and Technology Agency (JST) . The company will accelerate development of the artificial ligament for ACL reconstruction and business development for the US market.
2024-12-24
CoreTissue BioEngineering announces the renewal of its corporate website
2024-11-11
Yoji Jokura will present at ”The 62nd Annual Meeting of the Japanese Society for Artificial Organs”
2024-10-15
CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation